The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
you see this you know the myostatin Knockouts and you see this you know double muscle phenotype you would you know assume and you there is actual rodent data too where you see festat Administration does enhance muscle like it does happen
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and I remember like the chickens the mice the cattle I mean it was truly remarkable there's this dog too super Jack dog forget forget what type it is but uh he has the same m so my roommate and I spent the rest of medical school just talking about we've got to figure out a way to inhibit our myostatin yeah yeah okay so apparently now someone's working on this and they're claiming that for just I don't know $25,000 for your first shot and maybe 25,000 for every subsequent shot you can get a gene therapy that will activate and produce more of a protein called ftin that inhibits myostatin and so that be good right yeah yeah it seems like at least in the literature in animals you see this uh you know the myostatin Knockouts and you see this you know double muscle phenotype you would you know assume and you there is actual rodent data too where you see festat Administration does enhance muscle like it does happen